SCHEMBL29930889

SCHEMBL29930889

COc1cccc(-c2n[nH]c3ncc(Nc4ccccc4)cc23)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 6/20 0.69
DYRK1A Q13627 5/20 0.69
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
MAPK1 P28482 2/20 0.50
CYP2C19 P33261 2/20 0.50
HSD17B10 Q99714 2/20 0.50
BTK Q06187 1/20 0.50
CYP2D6 P10635 1/20 0.50
ADORA2A P29274 2/20 0.48
BRAF P15056 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ADORA1 P30542 1/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930702 0.90 DYRK1B (0.73) DYRK1BDYRK1ABTKTP53MAPT
SCHEMBL29930763 0.89 DYRK1B (0.71) DYRK1BDYRK1ACYP1A2CYP3A4CYP2C19
SCHEMBL29930701 0.88 DYRK1B (0.67) DYRK1BDYRK1AMAPK1ADORA2ABRAF
SCHEMBL29930851 0.81 DYRK1B (0.73) DYRK1BDYRK1AMAPK1LMNATP53
SCHEMBL29930966 0.80 KIT (0.50) DYRK1BDYRK1AHSD17B10BTKADORA2A
SCHEMBL29930535 0.80 GAA (0.49) DYRK1BDYRK1AADORA2AADORA1CLK4
SCHEMBL29930670 0.78 DYRK1B (0.70) DYRK1BDYRK1ABRAFABCG2KDR
SCHEMBL917608 0.72 MTNR1B (0.65) MAPK1MEN1KMT2ALMNATSHR
SCHEMBL30080139 0.72 MTNR1B (0.65) MAPK1MEN1KMT2ALMNATSHR
SCHEMBL674901 0.72 DYRK1B (0.54) DYRK1BDYRK1ACYP1A2MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO claimed
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed